Navigation Links
InVitria Sponsors ESACT 2009 in Dublin, Ireland
Date:6/5/2009

InVitria, a leading supplier of performance enhancing cell culture media supplements, to sponsor the 21st Meeting of the European Society for Animal Cell Technology (ESACT) in Dublin, Ireland from June 7-10, 2009.

Fort Collins, CO (PRWEB) June 5, 2009 -- The world-renowned ESACT '09 gathering will serve as host to scientific experts from academia and industry brought together to find "Cellular Solutions for Clinical Challenges." As one of the sponsors, InVitria will be sharing with attendees the powerful effects of its portfolio of cell culture media supplements developed to solve the regulatory and performance challenges facing the life science industry.

InVitria recently introduced a new product called ZAP-CHO, a performance enhancing cell culture media supplement designed to improve cell growth and antibody production in mammalian cell culture.

"ZAP-CHO improves CHO product development in chemically defined media that are completely free of animal components," said Steve Pettit, Ph.D., Director of Cell Culture Development with InVitria. "Previously, the performance enhancements gained with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum or fetal calf serum) in cell culture media," said Dr. Pettit.

Additionally, ZAP-CHO speeds-up cell line development and seed train expansion and also offers cost saving benefits by reducing operating costs as well as capital investment.

Recent publications, along with customer results has validated that another of InVitria's leading cell culture supplements, Cellastim, a recombinant human serum albumin, outperforms other forms of albumin for growth and productivity. Cellastim is a key component in stem cell media and is used to safely optimize performance in CHO and hybridoma cell lines.

"ESACT is a tremendous venue to build awareness of InVitria's product portfolio and collaborate with leaders in cellular biology," said Scott Deeter, InVitria President and CEO. "InVitria's products provide a unique opportunity for the cellular products industry to advance to a higher level of safety and productivity."

About InVitria InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's performance enhancing reagents, contact us at info(at)InVitria(dot)com or call 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/InVitria/ESACT/prweb2500704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria to Present at BIO 2009 International Convention in Atlanta
2. InVitria Reveals Technology to Optimize Hybridoma Production Performance
3. InVitria Headlines Sponsorship of WilBio's Waterside Conference
4. InVitria Announces Launch of Recombinant Albumin for Diagnostics
5. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
6. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
7. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
8. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
9. InVitria to Present at WilBio's International Cell Engineering Meeting
10. MEDai Helps Medicare Part D Sponsors Adhere to CMS Medication Therapy Management Initiative
11. UPMC Health Plan Sponsors School of Swing with MCG Jazz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology: